Stock ALSE ALSERES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Alseres Pharmaceuticals, Inc.

Equities

ALSE

US0211522026

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 11:36:50 18/10/2023 pm IST 		5-day change 1st Jan Change
0.005 USD -50.00% Intraday chart for Alseres Pharmaceuticals, Inc. -.--% -.--%
2015 Alseres Pharmaceuticals, Inc. cancelled the acquisition of E-IACFT Injection from Navidea Biopharmaceuticals, Inc. CI
2015 Alseres Pharmaceuticals, Inc. will Change its Ticker to ALSE from ALSED CI

Business Summary

Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). The Company's lead product candidate is Altropane. The Company's Altropane product is a molecular imaging agent used to diagnose Parkinson's disease and dementia. The Company is focused on entering into partnerships to ensure development and commercialization of its product.

Number of employees: 3

Sales per Business

USD in Million2012Weight2013Weight Delta
Diagnostic Products
100.0 %
1 100.0 % 0 100.0 % -10.74%

Sales per region

USD in Million2012Weight2013Weight Delta
United States
100.0 %
1 100.0 % 0 100.0 % -10.74%

Managers

Managers TitleAgeSince
Peter Savas CEO
 Chief Executive Officer 75 01/04/01

Members of the board

Members of the board TitleAgeSince
Peter Savas CEO
 Chief Executive Officer 75 01/04/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 12,000 0 0 33.80 %
Stock B 1 6,127 6,127 ( 100.00 %) 0

Shareholders

NameEquities%Valuation
Oppenheim Fonds Trust GmbH
0.0333 %
2 0.0333 % 0 $
Whatifi Asset Management, Inc.
0.000000 %
0 0.000000 % - $
NameEquities%Valuation
Bob Gipson
-
12,000 - 120 $

Company contact information

Alseres Pharmaceuticals, Inc.

275 Grove Street Suite 2-400

02466, Auburndale

+617-419-3289

http://www.alseres.com
address Alseres Pharmaceuticals, Inc.(ALSE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Diagnostic & Testing Substances Manufacturers

Sector Diagnostic & Testing Substances Manufacturers

1st Jan change Capi.
ALSERES PHARMACEUTICALS, INC. Stock Alseres Pharmaceuticals, Inc.
-.--% 30
DAAN GENE CO., LTD. Stock Daan Gene Co., Ltd.
-26.65% 1.37B
GENEREACH BIOTECHNOLOGY CORP. Stock GeneReach Biotechnology Corp.
-20.79% 56.08M
Diagnostic & Testing Substances Manufacturers
  1. Stock Market
  2. Equities
  3. ALSE Stock
  4. Company Alseres Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW